These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8068593)

  • 1. Rhabdomyosarcoma of the tongue.
    Doval DC; Kannan V; Acharya RS; Mukherjee G; Shenoy AM; Bapsy PP
    Br J Oral Maxillofac Surg; 1994 Jun; 32(3):183-6. PubMed ID: 8068593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonal rhabdomyosarcoma of the tongue in old age.
    Baldi A; Nicoletti G; Colella G; Pia Di Marino M; Persichetti P
    Oral Oncol; 2004 Apr; 40(4):450-2. PubMed ID: 14969826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? The experience of Italian and German Soft Tissue Sarcoma Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Brecht IB; Alaggio R; Cecchetto G; Provenzi M; Koscielniak E; Treuner J; Carli M
    Pediatr Blood Cancer; 2004 Feb; 42(2):134-8. PubMed ID: 14752876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children.
    Callender TA; Weber RS; Janjan N; Benjamin R; Zaher M; Wolf P; el-Naggar A
    Otolaryngol Head Neck Surg; 1995 Feb; 112(2):252-7. PubMed ID: 7838548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
    Smith LM; Anderson JR; Coffin CM
    Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
    Wang T; Gao X; Yang J; Guo W; Wu Z; Tang L; Cao S; Cai X; Liu T; Jia Q; Xiao J
    Clin Neurol Neurosurg; 2020 May; 192():105729. PubMed ID: 32058205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital rhabdomyosarcoma: a twenty-year survey in Turkey.
    Günalp I; Dürük K; Gündüz K
    Jpn J Ophthalmol; 1993; 37(4):499-504. PubMed ID: 8145396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Strategy for Pediatric Paratesticular Rhabdomyosarcoma Based on Chimeric Gene Assessment.
    Unno R; Mizuno K; Ito Y; Etani T; Okada A; Kawai N; Yasui T; Saitoh S; Hayashi Y
    Urology; 2016 Sep; 95():187-9. PubMed ID: 27017905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan.
    Fasina O
    Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcoma in children - current pathologic and molecular classification.
    Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D
    Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
    Yu L; Wang J
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood rhabdomyosarcoma: new insight on biology and treatment.
    Huh WW; Skapek SX
    Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
    Yang JC; Wexler LH; Meyers PA; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Takayama J; Ohira M; Yokoyama R; Beppu Y; Takaue Y
    Pediatr Hematol Oncol; 2003; 20(3):201-10. PubMed ID: 12637216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraosseous rhabdomyosarcoma of the mandible: a case report.
    Loducca SV; Mantesso A; de Oliveira EM; de Araújo VC
    Int J Surg Pathol; 2003 Jan; 11(1):57-60. PubMed ID: 12598923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
    Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
    J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonal rhabdomyosarcoma of the tongue.
    Cirocco A; González F; Sáenz AM; Jiménez C; Sardi JR; Oscar RF
    Pediatr Dermatol; 2005; 22(3):218-21. PubMed ID: 15916568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review.
    Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S
    Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.